JR-CTO Score for Percutaneous Treatment of Chronic Total Occlusions via Retrograde Approach

Technological advancements and technique improvements have significantly enhanced the success rate of percutaneous interventions for treating chronic total occlusions (CTO). Angiographic scores and CTO-PCI algorithms are valuable tools that help us select the optimal strategy when planning these procedures. The retrograde strategy, specifically, has proven beneficial in addressing complex CTOs. However, standardized tools to predict the success of this strategy have not yet been established.

¿Se justifica utilizar filtro de protección distal en los puentes venosos?

Therefore, the aim of this prospective non-randomized study was to develop a prediction tool that identifies CTO lesions that can be successfully treated via retrograde CTO-PCI.

The study included 2374 patients who underwent primary retrograde CTO-PCI and were registered in the Japanese CTO-PCI Expert Registry between January 2016 and December 2022. Observations were randomized to derivation and validation cohorts in a 2:1 ratio.

Read also: Catheter-Based Therapy for Pulmonary Embolism: Lower Mortality and Rehospitalization?

The JR-CTO score, which considers moderate-severe calcification, tortuosity, Werner collateral connection grade ≤1, and non-septal collateral channel, showed predictive capacity (C-statistic) for guidewire failure around 0.72 (95% confidence interval [CI]: 0.67-0.76) and 0.71 (95% CI: 0.64-0.77) in the derivation and validation cohorts, respectively. Patients with lower scores had higher rates of technical and guidewire success, as well as a reduction in both guidewire crossing time and procedure time (P <0.01).

Conclusion

The JR-CTO score, composed of four items, effectively predicts successful guidewire crossing in patients undergoing retrograde CTO-PCI. Patients with lower scores on this scale have higher rates of technical and guidewire success, and decreased procedure time and guidewire crossing time.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Retrograde Coronary Chronic Total Occlusion Intervention (JR-CTO) Score From the Japanese CTO-PCI Expert Registry.

Reference: Hiroyuki Tanaka, MD et al J Am Coll Cardiol Intv 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....